Table 4

Prevalence of metabolic dysregulations in patients with schizophrenia
MS ATP-III A All Frequency (%) Male Female OR (95% CI) and d (Cohen’s value) P Chi-Square value
WC (M > 102 cm; F > 88 cm) 114 (45.6%) 58 (31.9%) 56 (82.4%) 0.1 (0.05 – 0.2) d = −1.3 <0.01 50.9
FPG (≥100 mg/dL) 80 (32%) 52 (28.6%) 28 (41.2%) 0.6 (0.3 – 1.02) d = −0.28 0.06 3.6
HDL (M < 40 mg/dl; F < 50 mg/dl) 130 (52%) 87 (47.8%) 43 (63.2%) 0.53 (0.3 – 0.94) d = −0.35 0.03 4.7
BP (≥ 130/85 mmHg) 129 (51.6%) 92 (50.5%) 31 (45.6%) 1.2 (0.68 – 2.1) d = 0.1 0.55 0.35
TG (> 150 mg/dl) 123 (49.2%) 96 (52.7%) 33 (48.5%) 1.2 (0.7 – 2.1) d = 0.1 0.5 0.49

Abbreviations: MS, Metabolic syndrome; ATP-III, Adult Treatment Panel III; OR, Odds ratio; CI, confidence interval; WC, Waist Circumference; M, Male; F, Female; HDL, High-density lipoprotein; FPG, Fasting plasma glucose; BP, Blood pressure; TG, triglyceride.

Sweileh et al.

Sweileh et al. BMC Psychiatry 2012 12:235   doi:10.1186/1471-244X-12-235

Open Data